The current valuation score of Celularity Inc is 8.58, ranking 73 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -0.17, which is -6900.72% below the recent high of 11.34 and -1801.92% above the recent low of -3.17.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.